Ovarian Cancer Latest Advances

Efficacy and safety of trabectedin and pegylated liposomal doxorubicin in elderly patients: a subgroup analysis of a retrospective cohort.

Journal: Journal of chemotherapy (Florence, Italy)

Published: January 23, 2026

Retraction Note: Repression of LncRNA PART1 attenuates ovarian cancer cell viability, migration and invasion through the miR-503-5p/FOXK1 axis.

Journal: BMC cancer

Published: January 22, 2026

Preinvasive lesion creation prevalence of other HPV types other than HPV type 16-18.

Journal: Turkish journal of obstetrics and gynecology

Published: January 22, 2026

Correction: AOH induces oxidative stress and DNA damage in ovarian cancer cells via modulation of GPER1 and HIF1α/PI3K/CLDNs signaling pathway.

Journal: Scientific reports

Published: January 22, 2026

Secondary POLE Mutation Drives Metastasis in Hereditary Breast and Ovarian Cancer: Revealing Fallopian Tube Ultramutation.

Journal: JCO precision oncology

Published: January 21, 2026

The P7 peptide antagonizes bFGF-induced malignant behaviors of ovarian cancer by inhibiting MEK/ERK signaling pathway.

Journal: Future science OA

Published: January 21, 2026

Management of Suspected Stage IVA Endometrial Cancer With Rectosigmoid Involvement Using Neoadjuvant Chemotherapy and Interval Surgery.

Journal: Cureus

Published: January 21, 2026

Ex Vivo Microfluidic Model Identifies a Role for Shear Stress during Ovarian Tumor Cell Attachment to Peritoneal Mesothelial Cells.

Journal: ACS biomaterials science & engineering

Published: January 20, 2026

Qualitative study of information needs in advanced ovarian cancer: communication among patients, caregivers and healthcare providers regarding the disease, pharmacological treatment and non-pharmacological support.

Journal: BMJ open

Published: January 20, 2026

Correction to: CEBPB regulates ERK1/2 activity through SOS1 and contributes to ovarian cancer progression.

Journal: Medical oncology (Northwood, London, England)

Published: January 19, 2026

Clinical Outcomes of Sanshen Fuzheng Decoction in Preventing Chemotherapy-induced Neutropenia in Ovarian Cancer.

Journal: Journal of visualized experiments : JoVE

Published: January 19, 2026

Retraction Note: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer.

Journal: Oncogene

Published: January 16, 2026